ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Vifor Fresenius snap up rights to Cara’s itch therapy
pharmafile
May 25, 2018The joint partnership between Vifor Pharma and Fresenius Medical Care, Vifor Fresenius, has put down $50 in upfront cash and an equity investment of $20 million to gain the Ex-US, Japan and South Korea rights to Cara Therapeutics’ Korsuva.
Pharma Sources Insight January 2025
